BE-I-PLA2, a novel acidic phospholipase A2 from Bothrops erythromelas venom: isolation, cloning and characterization as potent anti-platelet and inductor of prostaglandin I2 release by endothelial cells

Biochem Pharmacol. 2006 Jul 28;72(3):377-84. doi: 10.1016/j.bcp.2006.04.032. Epub 2006 Jun 5.

Abstract

A novel acidic Asp49 phospholipase A(2) was isolated from Bothrops erythromelas (jararaca malha-de-cascavel) snake venom by four chromatographic steps. BE-I-PLA2 present a molecular weight of 13,649.57 Da as estimated by mass spectrometry. N-terminal and four internal peptides were sequenced, covering around one-third of the complete toxin sequence. The complete BE-I-PLA2 cDNA was cloned from a B. erythromelas venom-gland cDNA library. The cDNA sequence possesses 457 bp and encodes a protein with significant sequence similarity to many other phospholipase A(2) from snake venoms. When tested in platelet rich plasma, the enzyme showed a potent inhibitory effect on aggregation induced by arachidonic acid and collagen, but not ADP. On the other hand, BE-I-PLA2 did not modify aggregation in washed platelet. Furthermore, no action of BE-I-PLA2 on the principal platelets receptors was observed. Chemical modification with p-bromophenacyl bromide abolished the enzymatic activity of BE-I-PLA2, but its anti-platelet activity was only partially inhibited. In human umbilical-cord veins endothelial cells, BE-I-PLA2 was neither apoptotic nor proliferative but stimulated endothelial cells to release prostaglandin I(2), suggesting an increase of its potential anti-platelet activity in vivo. Further studies are required in order to determine the exact mechanism of action of BE-I-PLA2 in the inhibition of platelet aggregation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Apoptosis / drug effects
  • Bothrops / genetics*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cloning, Molecular
  • Crotalid Venoms / chemistry
  • Crotalid Venoms / genetics*
  • Crotalid Venoms / isolation & purification*
  • Crotalid Venoms / metabolism
  • Crotalid Venoms / pharmacology
  • DNA, Complementary / chemistry
  • DNA, Complementary / genetics
  • Dose-Response Relationship, Drug
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Epoprostenol / biosynthesis
  • Epoprostenol / metabolism*
  • Female
  • Group II Phospholipases A2
  • Group IV Phospholipases A2
  • Humans
  • Male
  • Molecular Sequence Data
  • Phospholipases A / genetics*
  • Phospholipases A / isolation & purification*
  • Phospholipases A / metabolism
  • Phospholipases A / pharmacology
  • Phospholipases A2
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / pharmacology
  • Reptilian Proteins
  • Sequence Analysis, DNA
  • Sequence Analysis, Protein
  • Sequence Homology, Amino Acid

Substances

  • Crotalid Venoms
  • DNA, Complementary
  • Platelet Aggregation Inhibitors
  • Reptilian Proteins
  • Epoprostenol
  • Phospholipases A
  • BE-I-PLA2 protein, Bothrops erythromelas
  • Group II Phospholipases A2
  • Group IV Phospholipases A2
  • Phospholipases A2

Associated data

  • GENBANK/DQ359953